GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Amyris Inc (FRA:3A01) » Definitions » ROE % Adjusted to Book Value

Amyris (FRA:3A01) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2023)


View and export this data going back to . Start your Free Trial

What is Amyris ROE % Adjusted to Book Value?

Amyris's ROE % for the quarter that ended in Mar. 2023 was 0.00%. Amyris's PB Ratio for the quarter that ended in Mar. 2023 was N/A. Amyris's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 was N/A.


Amyris ROE % Adjusted to Book Value Historical Data

The historical data trend for Amyris's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amyris ROE % Adjusted to Book Value Chart

Amyris Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -92.77 -

Amyris Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Amyris's ROE % Adjusted to Book Value

For the Specialty Chemicals subindustry, Amyris's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amyris's ROE % Adjusted to Book Value Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Amyris's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Amyris's ROE % Adjusted to Book Value falls into.



Amyris ROE % Adjusted to Book Value Calculation

Amyris's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Amyris's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amyris ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Amyris's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Amyris (FRA:3A01) Business Description

Industry
Traded in Other Exchanges
Address
5885 Hollis Street, Suite 100, Emeryville, CA, USA, 94608
Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and royalties from intellectual property, and grants, and collaborative research and development services.

Amyris (FRA:3A01) Headlines

No Headlines